DSpace DSpace Softwareについて English
 

GINMU >

ブラウズ : 著者 Akahane, Takemi

移動: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
あるいは、最初の数文字を入力してください:   
ソート項目: ソート順: 表示件数 表示著者数:
検索結果表示: 1 - 20 / 24
 次ページ >
発行日タイトル著者
2023年4月A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell ActivationSuzuki, Junya; Kaji, Kosuke; Nishimura, Norihisa; Kubo, Takahiro; Tomooka, Fumimasa; Shibamoto, Akihiko; Iwai, Satoshi; Tsuji, Yuki; Fujinaga, Yukihisa; Kitagawa, Koh; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi
2021年12月Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched-Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic RatsTakeda, Soichi; Kaji, Kosuke; Nishimura, Norihisa; Enomoto, Masahide; Fujimoto, Yuki; Murata, Koji; Takaya, Hiroaki; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi
2020年10月14日水曜日Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.Kitagawa, Koh; Moriya, Kei; Kaji, Kosuke; Saikawa, Soichiro; Sato, Shinya; Nishimura, Norihisa; Namisaki, Tadashi; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi
2020年6月19日金曜日Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.Tsuji, Yuki; Kaji, Kosuke; Kitade, Mitsuteru; Kaya, Daisuke; Kitagawa, Koh; Ozutsumi, Takahiro; Fujinaga, Yukihisa; Takaya, Hiroaki; Kawaratani, Hideto; Namisaki, Tadashi; Moriya, Kei; Akahane, Takemi; Yoshiji, Hitoshi
2024年2月Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitisTanaka, Misako; Kaji, Kosuke; Nishimura, Norihisa; Asada, Shohei; Koizumi, Aritoshi; Matsuda, Takuya; Yorioka, Nobuyuki; Tsuji, Yuki; Fujinaga, Yukihisa; Sato, Shinya; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi
2024年9月Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activityMatsuda, Takuya; Kaji, Kosuke; Nishimura, Norihisa; Asada, Shohei; Koizumi, Aritoshi; Tanaka, Misako; Yorioka, Nobuyuki; Tsuji, Yuki; Kitagawa, Koh; Sato, Shinya; Namisaki, Tadashi; Akahane, Takemi; Hitoshi, Yoshij